Welcome to Medications.com
Par Pharmaceutical Files Form 10-Qs for First and Second Quarters ... - Earthtimes
Sales of Megace(R) ES (megestrol acetate) oral suspension increased 124 percent to $19.1 million in the second quarter. Par's second-quarter gross margin ...
http://www.earthtimes.org/article... |
Posted: Wed Nov 21 06:03:16 -0500 2007
Megace ES RSS Feed
© 2002-2007, Skylabs Inc. |
About Us |
Disclaimer/Terms of Use |
Advertise |
Contact Us |
Site Map |
Developed by:
W3matter.com |
Sleep Apnea
